Encompass Health Corporation
EHC | NYSE
$135.24
-$0.66 (-0.49%)
Nov 2, 2026, 10:31 AM ET · Market open
Market Data
Market Cap $13.34B
Enterprise Value $16.13B
Beta 0.60
Average Volume 1M
Shares Outstanding (Diluted) 99.7M
Shares Change YoY -2.54%
Institutional Ownership 97.57%
Exchange NYSE
ISIN US29261A1007
Price Performance
Price Change 1M 12.9%
Price Change 3M 20.3%
Price Change 6M 26.8%
Price Change YTD 27.4%
Price Change 1Y 16.5%
Price Change 3Y 111.1%
Price Change 5Y 171.6%
1M CAGR (ann.) 11.8%
1Y CAGR (ann.) 9.0%
5Y CAGR (ann.) 20.5%
All-Time CAGR 17.2%
Valuation
PE Ratio 21.23
Forward PE 19.61
PEG Ratio 1.01
Forward PEG 1.22
PS Ratio 2.12
Forward PS 1.90
PB Ratio 5.00
P/FCF Ratio 29.32
P/Adj. FCF Ratio 33.64
P/OCF Ratio 10.25
EV/Sales 2.55
EV/EBIT 13.53
EV/EBITDA 10.39
EV/FCF 35.29
Earnings Yield 4.7%
FCF Yield 3.4%
Adj. FCF Yield 3.0%
Financial Health
Net Debt $2.52B
Total Debt $2.8B
Cash & Short-Term Investments $76.2M
Total Assets $7.57B
Current Ratio 1.09
Quick Ratio 1.09
Debt / Equity Ratio 1.05
Debt / EBITDA 1.81
Debt / FCF 6.13
OCF / Debt 0.47
Interest Coverage 9.14
Altman Z-Score 3.38
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 38.5%
Operating Profit Margin 18.3%
EBITDA Margin 24.5%
Net Profit Margin 10.2%
FCF Margin 7.2%
Adj. FCF Margin 6.3%
SBC / Revenue 0.9%
SBC Impact (per share) -12.8%
Returns
Return on Assets 8.5%
Return on Equity 25.2%
Return on Invested Capital 13.8%
Return on Capital Employed 17.5%
Return on Tangible Assets 10.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 10.6%
Revenue CAGR 5Y 6.0%
Revenue CAGR 10Y 5.9%
EPS CAGR 3Y 22.4%
EPS CAGR 5Y 9.5%
EPS CAGR 10Y 10.3%
FCF CAGR 3Y 20.7%
FCF CAGR 5Y 4.0%
FCF CAGR 10Y 0.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y 11.6%
Revenue Growth Next 3Y 9.6%
Earnings Date Feb 4, 2027
EPS Estimate (next Q) $1.59
EPS Growth Est (next Q) 8.9%
Revenue Est (next Q) $1.68B
Revenue Growth Est (next Q) 8.9%
Fair Value Estimates
Graham Number $72.23
Graham Upside -46.9%
Lynch Fair Value $60.99
Lynch Upside -55.1%
Price Target $154.83
Price Target Upside 13.9%
Cash Flow
Operating Cash Flow $1.3B
Free Cash Flow $457.2M
Adj. Free Cash Flow $398.5M
FCF Per Share $4.65
OCF Per Share $13.26
OCF/S Ratio 20.6%
Income Statement
Revenue $6.34B
Gross Profit $2.44B
Operating Income $1.16B
EBITDA $1.55B
Net Income $644.4M
EPS (Diluted) $6.40
Revenue / Employee $209.69K
Profit / Employee $21.32K
Employees 30,226
Dividends
Annual Dividend $0.78
Dividend Yield 0.57%
Payout Ratio 12.2%
FCF Payout Ratio 16.8%
Adj. FCF Payout Ratio 19.3%
Dividend Growth (YoY) 11.4%
Pay Frequency Quarterly
Ex-Dividend Date Jan 4, 2027
Add to Watchlist
Select watchlists to add or remove EHC